Lab Reagents
Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus ab ig reagents distributed by Genprice. The Cytomegalovirus Ab Ig reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Ab Group: Ig
Ig information
Cytomegalovirus p150 recombinant antigen |
|
8967 |
Virostat |
100 ug |
EUR 608.1 |
|
Description: This is Cytomegalovirus p150 recombinant antigen for ELISA,WB. |
Cytomegalovirus IgG ELISA Kit |
|
DEIA013 |
Creative Diagnostics |
96T |
EUR 858 |
|
Description: The CMV IgG ELISA is intended for use in the detection of Cytomegalovirus Antibody IgG in human serum. |
Cytomegalovirus IgG ELISA Kit |
|
DEIA326 |
Creative Diagnostics |
96T |
EUR 795.6 |
|
Description: Enzyme immunoassay for the quantitative determination of IgG antibodies against Cytomegalovirus in human serum and plasma. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2332-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2332-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2332SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2333-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2333-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
|
V2333SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus (CMV) Chimeric 1 Protein |
|
abx061513-1mg |
Abbexa |
1 mg |
EUR 1796.4 |
|
|
Cytomegalovirus Envelope Glycoprotein H Antibody |
|
20-abx109273 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
